Wexford Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-559
| Closed | -$254K | – | 147 |
|
|
2022
Q3 | $254K | Buy |
+559
| New | +$254K | 0.08% | 109 |
|
|
2021
Q1 | – | Sell |
-10,511
| Closed | -$3.38M | – | 248 |
|
|
2020
Q4 | $3.38M | Buy |
10,511
+3,502
| +50% | +$1.12M | 0.53% | 51 |
|
|
2020
Q3 | $1.88M | Sell |
7,009
-15,312
| -69% | -$4.11M | 0.5% | 49 |
|
|
2020
Q2 | $5.87M | Buy |
22,321
+8,321
| +59% | +$2.19M | 1.47% | 23 |
|
|
2020
Q1 | $3.18M | Buy |
14,000
+7,140
| +104% | +$1.62M | 1.18% | 29 |
|
|
2019
Q4 | $2.07M | Buy |
+6,860
| New | +$2.07M | 0.32% | 67 |
|
|
2018
Q4 | – | Sell |
-9,855
| Closed | -$2.7M | – | 96 |
|
|
2018
Q3 | $2.7M | Buy |
+9,855
| New | +$2.7M | 0.17% | 69 |
|
|
2018
Q1 | – | Sell |
-10,200
| Closed | -$2.3M | – | 121 |
|
|
2017
Q4 | $2.3M | Buy |
+10,200
| New | +$2.3M | 0.2% | 58 |
|
|
2016
Q3 | – | Sell |
-7,508
| Closed | -$986K | – | 169 |
|
|
2016
Q2 | $986K | Buy |
+7,508
| New | +$986K | 0.17% | 73 |
|
|
2014
Q4 | – | Sell |
-78,020
| Closed | -$9.33M | – | 68 |
|
|
2014
Q3 | $9.33M | Buy |
+78,020
| New | +$9.33M | 0.86% | 18 |
|
|
2014
Q1 | – | Sell |
-72,570
| Closed | -$6.71M | – | 199 |
|
|
2013
Q4 | $6.71M | Buy |
+72,570
| New | +$6.71M | 0.57% | 22 |
|